Global Immunosuppressant for Systemic Lupus Erythematosus
Table of Contents
2019-2024 Global Immunosuppressant for Systemic Lupus Erythematosus Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size 2014-2024
- 2.1.2 Immunosuppressant for Systemic Lupus Erythematosus Market Size CAGR by Region
- 2.2 Immunosuppressant for Systemic Lupus Erythematosus Segment by Type
- 2.2.1 Cyclophosphamide
- 2.2.2 Mycophenolate Mofetil
- 2.2.3 Azathioprine
- 2.2.4 Cyclosporine A
- 2.2.5 Tacrolimus
- 2.2.6 Methotrexate
- 2.2.7 Leflunomide
- 2.2.8 Vincristine
- 2.2.9 Other
- 2.3 Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
- 2.3.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate by Type (2014-2019)
- 2.4 Immunosuppressant for Systemic Lupus Erythematosus Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Pharmacy
- 2.4.4 Other
- 2.5 Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application
- 2.5.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth Rate by Application (2014-2019)
3 Global Immunosuppressant for Systemic Lupus Erythematosus by Players
- 3.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Market Share by Players
- 3.1.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size by Players (2017-2019)
- 3.1.2 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Market Share by Players (2017-2019)
- 3.2 Global Immunosuppressant for Systemic Lupus Erythematosus Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Immunosuppressant for Systemic Lupus Erythematosus by Regions
- 4.1 Immunosuppressant for Systemic Lupus Erythematosus Market Size by Regions
- 4.2 Americas Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth
- 4.3 APAC Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth
- 4.4 Europe Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth
- 4.5 Middle East & Africa Immunosuppressant for Systemic Lupus Erythematosus Market Size Growth
5 Americas
- 5.1 Americas Immunosuppressant for Systemic Lupus Erythematosus Market Size by Countries
- 5.2 Americas Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
- 5.3 Americas Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Immunosuppressant for Systemic Lupus Erythematosus Market Size by Countries
- 6.2 APAC Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
- 6.3 APAC Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Immunosuppressant for Systemic Lupus Erythematosus by Countries
- 7.2 Europe Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
- 7.3 Europe Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Immunosuppressant for Systemic Lupus Erythematosus by Countries
- 8.2 Middle East & Africa Immunosuppressant for Systemic Lupus Erythematosus Market Size by Type
- 8.3 Middle East & Africa Immunosuppressant for Systemic Lupus Erythematosus Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Immunosuppressant for Systemic Lupus Erythematosus Market Forecast
- 10.1 Global Immunosuppressant for Systemic Lupus Erythematosus Market Size Forecast (2019-2024)
- 10.2 Global Immunosuppressant for Systemic Lupus Erythematosus Forecast by Regions
- 10.2.1 Global Immunosuppressant for Systemic Lupus Erythematosus Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Immunosuppressant for Systemic Lupus Erythematosus Forecast by Type
- 10.8 Global Immunosuppressant for Systemic Lupus Erythematosus Forecast by Application
11 Key Players Analysis
- 11.1 Alcon
- 11.1.1 Company Details
- 11.1.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.1.3 Alcon Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Alcon News
- 11.2 Alkem Laboratories
- 11.2.1 Company Details
- 11.2.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.2.3 Alkem Laboratories Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Alkem Laboratories News
- 11.3 Allergan
- 11.3.1 Company Details
- 11.3.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.3.3 Allergan Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Allergan News
- 11.4 Amneal Pharmaceuticals
- 11.4.1 Company Details
- 11.4.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.4.3 Amneal Pharmaceuticals Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Amneal Pharmaceuticals News
- 11.5 Astellas Pharma
- 11.5.1 Company Details
- 11.5.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.5.3 Astellas Pharma Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Astellas Pharma News
- 11.6 Baxter
- 11.6.1 Company Details
- 11.6.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.6.3 Baxter Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Baxter News
- 11.7 Beijing Jialin Pharmaceutical
- 11.7.1 Company Details
- 11.7.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.7.3 Beijing Jialin Pharmaceutical Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Beijing Jialin Pharmaceutical News
- 11.8 Genentech
- 11.8.1 Company Details
- 11.8.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.8.3 Genentech Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Genentech News
- 11.9 Jubilant Cadista
- 11.9.1 Company Details
- 11.9.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.9.3 Jubilant Cadista Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Jubilant Cadista News
- 11.10 LGM Pharma
- 11.10.1 Company Details
- 11.10.2 Immunosuppressant for Systemic Lupus Erythematosus Product Offered
- 11.10.3 LGM Pharma Immunosuppressant for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 LGM Pharma News
- 11.11 LingNan Pharmaceutical
- 11.12 Merck
- 11.13 Mimetogen Pharmaceuticals
- 11.14 Mylan
- 11.15 Otsuka Pharmaceutical
- 11.16 Par Pharmaceutical
- 11.17 Pfizer
- 11.18 Powerdone
- 11.19 Regenerx Biopharmaceuticals
- 11.20 Roxane Laboratories
- 11.21 Sandoz
- 11.22 Sanofi
- 11.23 Santen Pharmaceutical
- 11.24 Shire
- 11.25 Sine
- 11.26 Strides Pharma
- 11.27 Talon Therapeutics
- 11.28 Teva
- 11.29 United Biotech
- 11.30 West Ward Pharmaceuticals
12 Research Findings and Conclusion
According to this study, over the next five years the Immunosuppressant for Systemic Lupus Erythematosus market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Immunosuppressant for Systemic Lupus Erythematosus business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Immunosuppressant for Systemic Lupus Erythematosus market by product type, application, key companies and key regions.
This study considers the Immunosuppressant for Systemic Lupus Erythematosus value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Cyclophosphamide
Mycophenolate Mofetil
Cyclosporine A
Tacrolimus
Methotrexate
Leflunomide
Vincristine
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinic
Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Alcon
Alkem Laboratories
Allergan
Amneal Pharmaceuticals
Astellas Pharma
Baxter
Beijing Jialin Pharmaceutical
Genentech
Jubilant Cadista
LGM Pharma
LingNan Pharmaceutical
Merck
Mimetogen Pharmaceuticals
Mylan
Otsuka Pharmaceutical
Par Pharmaceutical
Pfizer
Powerdone
Regenerx Biopharmaceuticals
Roxane Laboratories
Sandoz
Sanofi
Santen Pharmaceutical
Shire
Sine
Strides Pharma
Talon Therapeutics
Teva
United Biotech
West Ward Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Immunosuppressant for Systemic Lupus Erythematosus market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Immunosuppressant for Systemic Lupus Erythematosus market by identifying its various subsegments.
Focuses on the key global Immunosuppressant for Systemic Lupus Erythematosus players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Immunosuppressant for Systemic Lupus Erythematosus with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Immunosuppressant for Systemic Lupus Erythematosus submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.